MANULIFE FINANCIAL CORP
No enriched coverage for $MFC in the last 7 days.
No SEC Form 4 filings for $MFC in the last 30 days.
See all $MFC insider activity →Manulife CQS Investment Management seeks $1 billion for its CQS Regulatory Capital Relief Fund IV, targeting 13% annual returns. The fund invests in significant risk transfers (SRTs), which are growing in popularity among banks to offload risk. SRT sales in 2026's first half surpassed $18 billion, according to Crescent Capital Group LP.
Simply Wall St reports Manulife Financial (TSX:MFC) posted Q2 2026 net income of CA$2,181 million and basic EPS from continuing operations of CA$1.20, versus CA$1,874 million and CA$0.99 a year earlier. The article cites a 90-day share return of 19.35% and 1-year total shareholder return of 52.75%, and a fair value estimate of CA$63.87 versus CA$61.73, noting risks from U.S. credit losses and Asian fee-income pressure.
Manulife Holdings Bhd (KL:MANULFE) reported net profit rising to RM111.9 million in FY2025 ended Dec 31, 2025, up from RM23.4 million in FY2022, and net profit more than doubling to RM18.67 million in 1QFY2026. Revenue rose 7.2% to RM225.9 million. FY2025 annual premium equivalent grew 13%, AUM reached RM17.9 billion, and net DPS increased to nine sen. Shares were RM2.28 on July 17.
Recent MFC coverage spans financial news, earnings and corporate actions.
The fund raise signals strong demand for SRT strategies and could boost Manulife's asset‑management revenues.
The article frames Manulife as modestly undervalued after strong Q2 results, but flags U.S. credit-loss risk and Asian fee-income pressure.
Higher Manulife earnings momentum and dividend growth are supportive for MFC’s consolidated earnings and capital return narrative via its controlling stake.
Earnings momentum plus explicit risk-transfer should support valuation, though the article frames it as long-term rather than a near-term catalyst.
Earnings beat-style metrics plus a large biometric risk transfer and capital return plan likely support near-term sentiment, but morbidity and Canada disability risks remain key swing factors.
alphai scores every news story that mentions MFC with an AI model for sentiment and relevance, and aggregates insider trades from MANULIFE FINANCIAL CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.
Manulife CQS Investment Management seeks $1 billion for its CQS Regulatory Capital Relief Fund IV, targeting 13% annual returns. The fund invests in significant risk transfers (SRTs), which are growing in popularity among banks to offload risk. SRT sales in 2026's first half surpassed $18 billion, according to Crescent Capital Group LP.
2 min readSimply Wall St reports Manulife Financial (TSX:MFC) posted Q2 2026 net income of CA$2,181 million and basic EPS from continuing operations of CA$1.20, versus CA$1,874 million and CA$0.99 a year earlier. The article cites a 90-day share return of 19.35% and 1-year total shareholder return of 52.75%, and a fair value estimate of CA$63.87 versus CA$61.73, noting risks from U.S. credit losses and Asian fee-income pressure.
6 min readManulife Holdings Bhd (KL:MANULFE) reported net profit rising to RM111.9 million in FY2025 ended Dec 31, 2025, up from RM23.4 million in FY2022, and net profit more than doubling to RM18.67 million in 1QFY2026. Revenue rose 7.2% to RM225.9 million. FY2025 annual premium equivalent grew 13%, AUM reached RM17.9 billion, and net DPS increased to nine sen. Shares were RM2.28 on July 17.
6 min readThe S&P/TSX Composite rose 3.3% to a record 36,381, its best week in four months. The article highlights Manulife Financial (MFC) with Q2 core earnings up 12% to C$1.9B, core EPS up 16%, ROE 16.3%, and a C$61.78 price. It also cites Air Canada (AC) with Q1 revenue C$5.8B and free cash flow C$1.6B, trading near C$26.58.
4 min readManulife Financial (MFC) reported Q2 2026 results on an earnings call. Core EPS rose 16% YoY on 12% core earnings growth and share buybacks. Net income was $2.1B. APE sales grew 21% YoY, and adjusted book value per share was $41.12. The company transacted $3.2B LTC reserves with Munich Re and returned $1.4B to shareholders.
12 min readManulife Financial’s Q2 earnings call covered Hong Kong sales mix, China regulatory/tax enforcement questions, and Global Wealth and Asset Management flows. Manulife reported CAD 4 billion net inflows in Global WAM, core earnings up 9%, and LICAT 136%. It also announced a Munich Re reinsurance deal transferring CAD 3.2 billion long-term care reserves and expects CAD 30 million foregone core earnings in year one.
6 min readManulife Financial Corp (MFC) reported 2Q26 results for the quarter ended June 30, 2026. Core earnings were $1.9B, up 12% on a CER basis, and core EPS was $1.09, up 16% y/y. Net income to shareholders was $2.1B. APE sales rose 21% and new business CSM and NBV increased 16% and 10% y/y, respectively.
6 min readManulife Financial Corporation (MFC) announced quarterly dividends on several non-cumulative preferred share series. Dividends per share range from C$0.28125 to C$0.396875, payable on or after Sept. 19, 2026. Record date is Aug. 21, 2026, per the company.
2 min readIGM Financial’s asset manager Mackenzie reduced investment teams to nine from 15 to streamline costs and reinvest in AI, as part of IGM’s $95 million restructuring. IGM expects $70 million annual savings by end-2028. Mackenzie AUM was $268.8 billion in Q2, up 19.7% YoY, with Q2 net sales of $1.9 billion. IGM reported Q2 results under CEO Damon Murchison.
5 min readManulife Philippines said demand for financial products in the Philippines remains steady, shifting toward guaranteed-return products and faster-growing health products amid Middle East war-driven volatility and inflation, according to Rahul Hora and the 2026 Manulife Asia Care Survey. Executives also cited increased interest in offshore diversified global strategies.
3 min read
